免疫检查点代表了针对性治疗和骨髓质疏松综合征预后的有希望的突破
Xinyu Guo1, Shunjie Yu1, Xiaotong Ren1
1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, Heping District 154 Anshan Road, Tianjin, China.
Heliyon
|October 9, 2023
概括
骨髓质疏松症候群 (MDS) 是一种血液癌症. 本综述讨论了MDS的发病,当前的治疗方法,以及免疫调节和免疫蛋白在管理这种疾病中的新兴作用.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 骨髓发育综合征 (MDS) 是一种具有复杂病因的血液性恶性瘤.
- 目前对MDS的治疗方法侧重于控制疾病的进展,而不是提供治愈方法.
- 骨髓微环境和遗传因素在MDS发育中起作用.
研究的目的:
- 审查骨髓质疏松症候群 (MDS) 的病原性.
- 讨论目前MDS的治疗原则.
- 突出免疫调节和免疫蛋白在MDS管理和预后中的重要性.
主要方法:
- 关于MDS病变发生,治疗和免疫治疗的文献综述.
- 分析免疫系统在MDS发展中的作用.
- 在MDS预后中讨论免疫蛋白质.
主要成果:
- MDS的发病包括遗传突变,细胞表面抗原的改变,以及亲炎性骨髓微环境.
- 免疫调节正在成为MDS的有希望的治疗策略.
- 免疫蛋白质是MDS治疗和患者结果的重要因素.
结论:
- 了解MDS的发病因子对于开发有效的治疗方法至关重要.
- 免疫疗法,特别是免疫调节,为管理MDS提供了一种可行的方法.
- 免疫蛋白是预测MDS预后和指导治疗决策的重要生物标志物.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


